Journal of Hematology & Oncology 2024

4 papers
The Journal of Hematology & Oncology in 2024 focused on clinical trial outcomes, global epidemiological trends, and the implications of generative artificial intelligence in medical research. Notable clinical studies included the RESONANCE trial, a phase 3 study evaluating perioperative versus adjuvant chemotherapy for gastric cancer, and a phase 2 trial investigating reduced-dose chemotherapy combined with blinatumomab for B-cell precursor acute lymphoblastic leukemia. The year’s edition also featured a systematic analysis of the global burden of thyroid cancer from 1990 to 2021, utilizing socio-demographic indexing to map disease trends. Another prominent theme involved the intersection of technology and academic integrity. Research addressed the challenge of realistic experimental images generated by ChatGPT and the difficulty of distinguishing synthetic medical data from authentic media. Methodological work explored molecular signatures for precision prognosis and techniques for tracing synthetic content to specific generative models. Prolific contributors such as Peng Luo, Anqi Lin, and Jian Zhang represented these diverse research directions, spanning from neoadjuvant downstaging in advanced tumors to the detection of localized synthetic manipulations in scientific publications.

Institutions

Institutions credited by Journal of Hematology & Oncology 2024 papers: a paper credits every institution named in its affiliations, once. 7 institutions share 2 credited papers.

#InstitutionPapersShare20232023 rank
1Shanghai Jiao Tong University 2100.0%0—
202mhxa927 150.0%0—
3Chinese Academy of Medical Sciences & Peking Union Medical College 150.0%13
4National Cancer Center 150.0%0—
5Shanghai First People's Hospital 150.0%0—
6Southern Medical University 150.0%0—
7TU Wien 150.0%0—

Download all institutions as CSV

About this data

Papers. Journal of Hematology & Oncology 2024 lists 4 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 4 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: institutions. Cite as: Lacuna, “Journal of Hematology & Oncology 2024”, https://lacuna.tiptreesystems.com/venue/journal-of-hematology-oncology/2024.

Top Authors

AuthorPapers
Shuo Li1

Papers

Title
ChatGPT’s ability to generate realistic experimental images poses a new challenge to academic integrity
Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial